622

Shares

The race to create a new class of ovarian cancer drugs heats up

Shared by Radhika Narayanan | 621 0 1 | about 9 months ago

Ovarian cancer has historically been one of the harder cancers to treat — but a promising new class of drugs, called PARP inhibitors, is proving powerful in delaying the growth of tumors by preventing cancer cells from repairing themselves after they’ve been damaged by chemotherapy.

Read More On www.pbs.org

Categories Digital chemistry & Pharma IT

Related Post

Links

http://www.pbs.org/newshour/rundown/ovarian-cancer-drugs/
http://www.pbs.stfi.re/newshour/rundown/ovarian-cancer-drugs/?sf=vooxwan
http://stfi.re/vooxwan
http://to.pbs.org/2e38gw0

0 Votes

You must log in to post a comment

0 Comments